Ved anvendelse af 200 mg tolcapon tre gange daglig er erytrocyt- COMT- hæmningen ved laveste niveau 30% til 45%, uden udvikling af tolerance.
During dosing with Tasmar 200 mg three times daily, erythrocyte COMT inhibition at trough is 30% to 45%, with no development of tolerance.